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The purpose was to determine the possible effects of exercise and/or caffeine on hypoglycemia and liver
gluconeogenesis in diabetic rats. These were divided into four subgroups: (a) intraperitoneal insulin only,
(b) exercise bout before insulin, (c) caffeine after insulin, and (d) exercise bout before and caffeine after insulin.
The marked glycemic drop 45 min after insulin (0 min= 229.00, 45 min= 75.75) was considerably reduced (p<
0.05) by caffeine or exercise (45 min: exercise= 127.00, caffeine= 104.78). However, this systemic effect was lost
(p> 0.05) when they were combined (45 min: exercise+ caffeine= 65.44) (Mean, in mg·dL−1). Caffeine alone
strongly inhibited liver glucose production from 2 mM lactate 45 min after insulin (without caffeine= 3.05, with
caffeine= 0.27; p< 0.05), while exercise+ caffeine partially re-established the liver gluconeogenic capacity
(exercise+ caffeine= 1.61; p< 0.05 relative to the other groups) (Mean, in μmol·g−1). The improved hypoglycemia
with caffeine or exercise cannot be explained by their actions on liver gluconeogenesis. As their beneﬁcial effect
disappeared when they were combined, such association in diabetic patients should be avoided during the period of
hyperinsulinemia due to the risk of severe hypoglycemia.
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Introduction
The maintenance of glycemia is a ﬁnely tuned mechanism that demands the integration of
glucose absorption, production, and uptake (30), as well as the presence of signaling
molecules such as insulin, glucagon, adrenaline, adenosine, and others (13). The liver is
a multifunctional organ with an active role on this process, operating as a glycemic buffer by
promoting synthesis/degradation of the glycogen store as well as synthesizing new glucose
molecules (gluconeogenesis) (31). These metabolic pathways are constantly modulated by
many factors, such as nutritional condition and physical activity (5).
The metabolic disorder resulting from lack of insulin is known as type 1 diabetes
mellitus (T1DM) (11, 32, 39). It is characterized by an unbalanced increase in glycemia that
demands the use of exogenous insulin to normalize the blood glucose levels and preserve
homeostasis.
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Many T1DM patients are young and physically active, and exercise in T1DM can trigger
adverse effects such as hypoglycemia and hyperglycemia. More than 30% of children and
youngsters with T1DM show hypoglycemic episodes during an exercise session. On the other
hand, hyperglycemia disrupts the metabolic and vascular beneﬁts of exercise (20). Despite an
intense and rigorous glycemic control preventing the secondary complications of diabetes,
there is an intrinsic inability in regulating glucose concentration during and after exercise.
In addition, nocturnal hypoglycemia is common in T1DM on the night following exercise
and, as in a vicious cycle, the response to exercise on the following session is impaired (10).
There are many substances that interfere with the glycemic control, such as caffeine
(1,3,7-trimethylxanthine), found in products widely consumed such as coffee, tea, guarana,
chocolate, and medications (3, 16, 28, 47). Caffeine is avoided in some cases, such as
autosomal dominant polycystic kidney disease, due to prior awareness of the patients of need
for restriction, because caffeine may induce cyst and kidney enlargement (45). However, in
other cases, in spite of not having nutritional value, caffeine has been used as an ergogenic
substance because it improves performance in long-term physical activities. The ergogenic
effect of caffeine is reversible and seems to be mediated by central and peripheral
mechanisms of action that can trigger physiological and metabolic changes (19, 38, 40,
44). At ﬁrst, the action of caffeine was linked to an increase in the serum concentration of
adrenaline and noradrenaline, which would lead to the enhanced oxidation of free fatty acids
and saving of glycogen by the muscle tissue (9, 19, 25, 38, 40, 44), but adenosine receptor
antagonism seems to be the major mechanism of action of caffeine (4).
Adenosine is a ubiquitous cellular constituent released from the hydrolysis of adenosine
triphosphate (ATP) in the extracellular space or intracellularly; the newly formed adenosine is
exported to the extracellular space by speciﬁc nucleoside transporters (12, 22, 49). In the
extracellular space, adenosine can bind to four different G-protein coupled receptors. The A1 and
A3 receptors inhibit adenylyl cyclase, while the A2a and A2b receptors activate the enzyme (43).
In the liver, the adenosine receptors can have many roles concerning glucose metabolism
regulation, lipolysis, and inﬂammation (23, 37, 48). An increase in the expression of these
receptors in the liver in adverse conditions like diabetes could link their activities with the
pathogenesis of liver complications in T1DM (7, 15, 21, 29). In addition, situations that increase
the levels of ATP hydrolysis, such as exercise and T1DM, are accompanied by increased levels of
adenosine (10, 35). This study assessed the in vivo glycemic response of T1DM rats made
hypoglycemic by insulin injection, as well as their liver gluconeogenic activity, in the presence of
exercise, and/or caffeine. The purpose was to determine the possible synergistic or antagonistic
effects of these agents on the drop and recovery of glycemia. Particularly, in situ liver perfusion
assessed the liver contribution to the glycemic response observed. Exercise and caffeine both had
a beneﬁcial effect on the glycemic proﬁle of T1DM rats during the hypoglycemic episode.
However, when combined, these effects disappeared. In addition, the in vivo glycemic proﬁle
could not be readily explained by the observed liver gluconeogenesis, indicating that the systemic
effects of exercise and caffeine are much more complex than their hepatic effects.
Materials and Methods
Materials
Regular human insulin (Novolin®) was obtained from Novo Nordisk (Brazil). Alloxan was
obtained from Sigma (Brazil). All other chemicals used had high degree of purity.
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Animals
All experimental procedures were approved by The University of Maringá Ethics Committee
(CEAE no. 002/2010 and CEAE no. 069/2013). Male Wistar rats (Rattus norvegicus)
weighing 180 g and aging 59 days were kept at the animal house of the Department of
Physiological Sciences under controlled temperature (23 °C) and photoperiod (12 h light/12 h
dark). Water and balanced Nuvital® chow were given freely until the day before the
experiment, when the chow was removed, so that the animals had a 14 h fasting (overnight)
at the beginning of the experimental protocols. For the in vivo experiments, the animals
remained under fasting until the end of the protocols, when they were returned to their cages.
Diabetes induction
The animals were given an intravenous injection of alloxan (40 mg·kg·bw−1). After 4 days,
the glycemia during the fasted state was checked through the caudal vein using glucose test
strips and a glucometer (Optium Xceed). All animals having fasting blood glucose values
≥200 mg·dL−1 were included in the study. The experimental protocols were carried out on
the following day.
Experimental groups
For both the in vivo and in situ experiments, the type 1 diabetic animals (T1DM) were divided
into four subgroups. Those receiving insulin injection (T1DM+I), those subjected to an acute
exercise bout before insulin injection (T1DM+E+I), those given caffeine 15 min after insulin
injection (T1DM+I+C), and those subjected to an acute exercise bout before and given
caffeine 15 min after insulin injection (T1DM+E+I+C).
Exercise bout
The exercise bout (groups T1DM+E+I and T1DM+E+I+C) consisted of a run in a
programmed treadmill (KT3000, Ibramed, Brazil), adapted for training rats. The animals
did not have an adaptation period before the experiments. Initial treadmill speed was
0.5 km·h−1, with progressive increases of 0.2 km·h−1 every 2 min, until exhaustion,
characterizing an acute exercise bout. Exhaustion was determined through visual observation
and deﬁned as the moment when the animal could not keep up with the treadmill speed.
Insulin was given immediately after exhaustion.
Insulin-induced hypoglycemia (IIH)
Hypoglycemia was induced in all the groups through intraperitoneal (ip.) injection of regular,
fast-acting insulin (1 U·kg·bw−1). The glycemia of the animals was recorded through the caudal
vein using glucose test strips and a glucometer (OptiumXceed) during 5 h after insulin injection
(times 0, 15, 30, 45, 60, 120, 180, and 300 min). The values were expressed as mg·dL−1.
Caffeine administration
Caffeine was administered orally (gavage) at a dose of 5 mg·kg·bw−1 15 min after the ip.
injection of regular insulin (T1DM+I+C and T1DM+E+I+C), while the other groups were
given an equivalent volume of saline.
In situ liver perfusion
The perfusion system is composed of vessels for the perfusion ﬂuid, a peristaltic pump and a
membrane oxygenator, coupled to a water bath with external circulation of warm water and a
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cylinder of carbogenic mixture (O2/CO2= 95/5%). The perfusion ﬂuid used was Krebs-
Henseleit-bicarbonate (KH) with pH 7.4 at 37 °C. Forty-ﬁve minutes after insulin injection
(the time of the lowest glycemia of the T1DM+I group, see Fig. 2), animals were ip.
anesthetized with sodium pentobarbital (40 mg·kg·bw−1) and subjected to laparotomy. The
portal vein was cannulated under low ﬂux (1 mL·min−1·g−1) and another cannula was
inserted into the inferior cava vein to allow the rapid exsanguination of the liver while the ﬂux
was elevated to about 4 mL·min−1·g−1 to assure an adequate supply of oxygen to the organ.
After 30 min of perfusion for the stabilization of the preparation, samples of the efﬂuent ﬂuid
were collected each 5 min for further biochemical assays. During the ﬁrst 10 min of
collection, the perfusion was made with KH alone and then L-lactate was added to the KH as
gluconeogenic precursor for 20 min, at a concentration of 2 mM, a near-physiological blood
value during fasting (2).
Demonstrative experiment for the calculation of the area under the curve
After a perfusion period of 10 min (basal glucose production), L-lactate was dissolved in the
perfusion ﬂuid and perfused from the 10th to the 30th min. Samples of the efﬂuent ﬂuid were
collected at 5-min intervals and the glucose concentrations were determined (6). The
difference in the glucose production during the perfusion with L-lactate and the basal
glucose production was used to calculate the area under the curve (AUC), whose value was
expressed in μmol·g−1 liver (Fig. 1). The AUCs in Fig. 3 and Table I were obtained from
similar procedures.
Determination of glucose and pyruvate in the perfusate
Glucose was measured by the glucose-oxidase method (6) and pyruvate by a previously
described technique (8). The values of glucose and pyruvate in the perfusate samples were
expressed in μmol·min−1·g−1 liver.
Statistical Analysis
The results [mean ± standard deviation (SD) of 6–10 experiments per group] were assessed
through student’s t-test, using the T1DM+I as the reference group, with the software
GraphPad Prism 5.0. The signiﬁcance level was set at 5%.
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Fig. 1. Demonstrative experiment
of the glucose production
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L-lactate in liver perfusion of
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Results
The values of the fasting glycemia were similar across all the experimental groups. The
T1DM animals previously subjected to exercise had a tendency of having a higher glycemia
than those non-exercised; however, differences were not statistically signiﬁcant (time 0 min,
Fig. 2). In these same groups, the pre- and post-exercise glycemia were not statistically
different either (p> 0.05 not shown). The time to exhaustion was similar in all the exercised
groups and was of 8 min 20 s on average.
Figure 2 shows that soon after insulin injection hypoglycemia was established in all
groups and reached the lowest values within the ﬁrst 45 min. The diabetic group (T1DM+I)
did not recover glycemia until time 300 min. However, exercise prior to insulin injection
reduced the intensity of the hypoglycemic episode since time 15 min. The administration
of caffeine resulted in a better hypoglycemic proﬁle at times 30 and 45 min and better
glycemia recovery at 300 min. On the other hand, the association of exercise and caffeine
(T1DM+E+I+C) resulted in a severe hypoglycemic crisis after 45 min, similar to the group
given only insulin (T1DM+I). Nevertheless, it did not interfere with the capacity of glycemia
recovery observed at 300 min. Therefore, exercise, caffeine, and the combination of both
promoted a signiﬁcant recovery at 300 min.
Considering that the hypoglycemic proﬁle was attenuated by either exercise or caffeine,
but not their association, a possible effect of the treatments on the liver glucose metabolism was
investigated through the in situ liver perfusion. As the lowest glycemic values were found
45 min after insulin injection, this time was chosen for the liver experiments (Fig. 3, Table I).
As for the liver glucose production from L-lactate (Fig. 3), it was observed that the
previous exercise bout did not change this pathway (p> 0.05). However, liver
Table I. Liver pyruvate production from 2 mM L-lactate in T1DM+I, T1DM+E+I, T1DM+I+C, and T1DM+E+I+C
rats. The AUCs are expressed in μmol·g−1 liver as mean ± SD of six to eight perfusion experiments
Group Pyruvate production (μmol·g−1)
T1DM+I 4.97 ± 0.38
T1DM+E+I 6.68 ± 0.39*
T1DM+I+C 6.06 ± 0.43*
T1DM+E+I+C 4.86 ± 0.30
*p< 0.05 vs. T1DM+I
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gluconeogenesis was about 10 times lower in the presence of caffeine. Importantly, it was
also observed that the association of exercise and caffeine partially re-established the liver
capacity of producing glucose from lactate.
As L-lactate is oxidized to pyruvate to be converted to glucose, the liver production of
pyruvate from L-lactate was also measured in the perfused liver (Table I). It was observed that
in the presence of exercise or caffeine, there were higher pyruvate values than on the other
treatments.
Discussion
The in vivo results showed that insulin-injected T1DM rats had a hypoglycemic episode that
did not recover completely after 300 min (Fig. 2, group T1DM+I).
Since exercise and insulin alone cause an amplifying effect on the number of active
GLUT4, which intensiﬁes the glucose use by the skeletal muscle cells (33, 34), it was
expected that their combination would worsen the hypoglycemia. However, the association
of insulin and exercise (Fig. 2, group T1DM+E+I) prevented the lowering of the glycemia to
the values of the T1DM+I group. This observation can be explained by the fact that exercise
also increases the release of catecholamines, which cause liver gluconeogenesis and glucose
release and stimulates lipolysis and the release of free fatty acids in the adipose tissue (17).
This scenario demonstrates that exercise could prevent a more severe hypoglycemia and have
an important role in the glycemic control in T1DM.
On the other hand, caffeine caused a less pronounced drop of the glycemic level at 30,
45, and 300 min (group T1DM+I+C, Fig. 2), but it was not different from the T1DM+I
group from 60 to 180 min, i.e., caffeine demonstrated a biphasic effect, an acute effect at 30
and 45 min (higher blood insulin), and a long-term effect at 300 min (after blood insulin
dissipation). The antagonistic effects of caffeine on the adenosine receptors are its major
mechanism of action (4). These receptors are found in muscle, liver, and adipose tissue, all of
them heavily involved in blood glucose homeostasis. In adipose tissue (A1-subtype
receptors), caffeine could result in increased lipolysis and a glucose-saving systemic effect
(3, 19, 24, 25, 27, 38); however, by antagonizing adenosine receptors on skeletal muscle (also
A1-subtype receptors), caffeine increases glycolysis (27). In addition, adenosine receptors in
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Fig. 3. Liver glucose production
from 2 mM L-lactate in T1DM+I,
T1DM+E+I, T1DM+I+C, and
T1DM+E+I+C rats. The AUCs are
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experiments. *p< 0.05 vs. T1DM+I,
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the liver stimulate gluconeogenesis, glycogenolysis, and glucose release (14, 15, 18, 21, 27,
36), all of which could be potentially antagonized by caffeine.
Although caffeine also stimulates the release of catecholamines, the dose should be at
least 20 times greater than that used in these experiments (47). It seems that at the dose of
caffeine employed (5 mg·kg·bw−1), there is a predominance of the antagonistic effect on the
adenosine receptors. This adenosine antagonism by caffeine is the sum of all its effects on
many tissues, and may be dependent, among other things, on the relative amount of muscle –
resulting in glucose consumption – and fat – resulting in glucose sparing (25), in addition to
its effects on the liver.
The possibilities listed could result in the less severe hypoglycemic proﬁle of the
T1DM+E+I and T1DM+I+C groups. Within this reasoning, we can argue that exercise and
caffeine efﬁciently antagonized hypoglycemia and decreased the glycemic drop, especially
during the ﬁrst 45 min after insulin injection, leading to a less marked hypoglycemic proﬁle.
On the other hand, the association of exercise and caffeine (Fig. 2, T1DM+E+I+C) caused a
glycemic drop similar to insulin (group T1DM+I) between 45 and 180 min. In this case, caffeine
may have progressively inhibited the effect of exercise on the muscle cells, so that from 45 to
180 min, the anti-hypoglycemic effects of exercise were completely overcome by caffeine. This
may have been caused by caffeine competitively inhibiting the binding of extracellular adenosine
with its membrane receptors, which would tend to increase glycolysis and glucose uptake in
muscle cells and decrease glucose production and release from the liver (10, 17, 24, 35, 42).
However, both exercise and caffeine, either isolated or associated, had a residual effect
and markedly recovered the glycemia after insulin disappearance (Fig. 2, 300 min), probably
but not exclusively due to an increased lipolysis powered by caffeine and exercise-derived
catecholamines (26, 38, 41, 46). It seems that both exercise and/or caffeine are effectively
acting as long-term counter-regulatory mechanisms, as judged from the improved glycemia
(compared to group T1DM+I) 300 min after insulin injection.
In non-diabetic animals, differently from the T1DM animals, the hypoglycemic proﬁle
is not changed by either exercise or caffeine; instead, their association results in a better
hypoglycemic proﬁle (4). This difference is most certainly due to the diabetic condition of the
animals in this study, because diabetes changes the signaling capacities of many substances
(such as exercise-derived catecholamines and adenosine) on the major tissues involved in the
response to hypoglycemic conditions, i.e., skeletal muscle, liver, and adipose tissue.
The conversion of L-lactate to pyruvate is the crucial step for L-lactate to be used as
gluconeogenic precursor. Liver pyruvate production (Table I) had a qualitative resemblance
to the in vivo glycemic proﬁle of the groups 45 min after insulin injection: lower values in the
T1DM+I and T1DM+E+I+C groups and higher values in the T1DM+E+I and T1DM+I+C
groups. Although the groups have shown increased production of pyruvate, the production of
glucose was reduced in the groups T1DM+I+C and T1DM+E+I+C (Fig. 3). It is possible
that, in these groups, pyruvate was being diverted to some other cellular pathway, such as that
of nitrogen rescue. Therefore, further studies are needed to substantiate these results.
Exercise (T1DM+E+I) did not signiﬁcantly change the liver gluconeogenic capacity
from L-lactate during hypoglycemia when compared to the T1DM+I group (Fig. 3). As the
hypoglycemic proﬁle of these two groups were signiﬁcantly different at 45 min of the IIH –
the time chosen to assess liver gluconeogenesis – the liver glucose production from L-lactate
cannot account for the difference observed in vivo. In this case, the extra-hepatic effects of
exercise discussed above predominate over the liver effects, and manifest as variation in
blood glucose levels.
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On the other hand, caffeine (T1DM+I+C) caused a marked reduction of the liver
glucose production from L-lactate. It is possible that caffeine efﬁciently blocked the liver
adenosine receptors (7, 44), making way to an enhancement of the inhibitory effect of insulin
on the liver glucose production. This suggestion is consistent with the inhibition of
A3-subtype receptors (8, 29) and with the results of the in situ liver perfusion for the
T1DM+I+C group (Fig. 3). However, as hypoglycemia was less severe with caffeine 45 min
after insulin injection, extra-hepatic effects were probably predominant. When exercise and
caffeine were associated (group T1DM+E+I+C, Fig. 3), liver glucose production was
partially restored. Exercise promotes catecholamine release and increased levels of endoge-
nous adenosine (1, 5, 10), both of which could have partially overcome the inhibitory effect
of caffeine on liver gluconeogenesis from L-lactate.
Conclusions
In summary, the correlation of the liver glucose production from L-lactate with the
hypoglycemic proﬁle of the diabetic animals shows that the systemic effects of exercise
and caffeine are much more complex than their hepatic effects, so that the in vivo glycemic
proﬁle cannot be readily explained by the observed liver gluconeogenesis. This suggests that
the systemic effects of exercise and caffeine on the glycemic levels are also dependent upon
their actions on other important targets, such as skeletal muscle and adipose tissue. Finally,
both exercise and caffeine have a beneﬁcial effect on the glycemic proﬁle of T1DM rats
during the decay phase hypoglycemic episode. However, when combined, these effects
disappear and therefore the association of exercise and caffeine in T1DM should be avoided
during the period of hyperinsulinemia due to the risk of severe hypoglycemia.
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